Key facts
- Summit Therapeutics co-CEO Zanganeh Mahkam bought $1.46 million of company stock.
- The transaction was disclosed in a recent filing.
Summit Therapeutics co-CEO Zanganeh Mahkam has acquired $1.46 million worth of the company's stock. This significant purchase was made public through a recent regulatory filing, indicating insider confidence in the company's prospects.